These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 2079272)

  • 41. [Significance of CA19-9 in mature cystic teratoma].
    Ito K
    Nihon Sanka Fujinka Gakkai Zasshi; 1992 May; 44(5):524-8. PubMed ID: 1619311
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A comparative study of mucin-like carcinoma-associated antigen (MCA), CA 125, CA 19-9 and CEA in patients with ovarian cancer.
    Koelbl H; Schieder K; Neunteufel W; Bieglmayer C
    Neoplasma; 1989; 36(4):473-8. PubMed ID: 2770933
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Higher levels of soluble E-cadherin in cyst fluid from malignant ovarian tumours than in benign cysts.
    Sundfeldt K; Ivarsson K; Rask K; Haeger M; Hedin L; Brännström M
    Anticancer Res; 2001; 21(1A):65-70. PubMed ID: 11299791
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [High CA-125 values in a patient with miliary tuberculosis and ascites].
    Klein M; Marczewski A; Rosen A; Beck A
    Gynakol Rundsch; 1989; 29 Suppl 2():355-6. PubMed ID: 2613049
    [No Abstract]   [Full Text] [Related]  

  • 45. Expression of monoclonal antibody-defined tumor markers in four carcinomas.
    Wu JT
    Ann Clin Lab Sci; 1989; 19(1):17-26. PubMed ID: 2916833
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Detection of CA 125 in the serum and tissue of patients with ovarian neoplasms].
    Kristen P; Beier HJ; Kaesemann H; Caffier H
    Gynakol Rundsch; 1989; 29 Suppl 2():358-60. PubMed ID: 2693257
    [No Abstract]   [Full Text] [Related]  

  • 47. [Does follow-up of false-negative CA-125 serum values in tumor after-care of ovarian cancer make sense?].
    Sevelda P; Rosen A; Barrada M; Gober S; Vavra N; Salzer H
    Gynakol Rundsch; 1990; 30 Suppl 1():210-1. PubMed ID: 2079273
    [No Abstract]   [Full Text] [Related]  

  • 48. Measurement of a monoclonal-antibody-defined antigen (90K) in the sera of patients with ovarian cancer.
    Scambia G; Panici PB; Baiocchi G; Perrone L; Iacobelli S; Mancuso S
    Anticancer Res; 1988; 8(4):761-4. PubMed ID: 3178164
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Expression of mucin-like carcinoma-associated antigen in the cyst fluid differentiates mucinous from nonmucinous pancreatic cysts.
    Sperti C; Pasquali C; Pedrazzoli S; Guolo P; Liessi G
    Am J Gastroenterol; 1997 Apr; 92(4):672-5. PubMed ID: 9128321
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Elevated serum RANTES levels in patients with ovarian cancer correlate with the extent of the disorder.
    Tsukishiro S; Suzumori N; Nishikawa H; Arakawa A; Suzumori K
    Gynecol Oncol; 2006 Sep; 102(3):542-5. PubMed ID: 16510173
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Tumor markers in ovarian cancer].
    Lahousen M
    Jugosl Ginekol Perinatol; 1987; 27(3-4):73-5. PubMed ID: 3481005
    [No Abstract]   [Full Text] [Related]  

  • 52. [Ovarian cysts. The respective role of clinical examination, echography, biological markers and cytology].
    Forest AM; Brémond A; Lévèque J; Viallet A
    J Gynecol Obstet Biol Reprod (Paris); 1990; 19(7):829-36. PubMed ID: 2277165
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [A case of metaplastic Brenner tumor with elevated serum CA19-9 levels].
    Nishikawa A; Fukushima M; Shimano S; Yamakawa Y; Hashimoto M; Satoh M
    Nihon Sanka Fujinka Gakkai Zasshi; 1990 Nov; 42(11):1579-82. PubMed ID: 2273316
    [No Abstract]   [Full Text] [Related]  

  • 54. [Gigantic pseudomucinous cyst simulating inoperable malignant ovarian tumor].
    Gerasimenko AA; Zakharov VP; Loĭko IK; Shkrobot VT; Gerasimenko EA
    Vestn Khir Im I I Grek; 1977 Apr; 118(4):123-4. PubMed ID: 867701
    [No Abstract]   [Full Text] [Related]  

  • 55. Intracystic evaluation of tumor markers in benign and malignant ovarian pathology.
    Cherchi PL; Capobianco G; Ambrosini G; Fadda GM; Piga MD; Ruiu G; Fattorini F; Dessole S
    Eur J Gynaecol Oncol; 2002; 23(2):163-5. PubMed ID: 12013118
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Cysts and cystomas].
    Onika MD
    Med Sestra; 1977 Aug; 36(8):28-30. PubMed ID: 244741
    [No Abstract]   [Full Text] [Related]  

  • 57. [Tumor marker (CA19-9, DU-PAN 2, SPAN 1) levels in cystic fluid of benign liver cyst: preliminary report].
    Iwase K; Takenaka H; Yagura A; Oshima S; Nishimura Y; Yoshidome K; Tanaka T
    Nihon Geka Gakkai Zasshi; 1992 Aug; 93(8):872. PubMed ID: 1435720
    [No Abstract]   [Full Text] [Related]  

  • 58. [Ovarian tumors].
    Cayrol M; Ouldamer L; Marret H
    Rev Prat; 2013 Feb; 63(2):259-65. PubMed ID: 23513798
    [No Abstract]   [Full Text] [Related]  

  • 59. [Difficulties associated with the diagnosis of dysgerminoma in girls].
    Martincík J; Uher M
    Cesk Gynekol; 1975 Mar; 40(2):101. PubMed ID: 1131915
    [No Abstract]   [Full Text] [Related]  

  • 60. [Tumor markers in malignant ovarian tumors].
    Kudela M; Fingerová H; Gebauer T
    Cesk Gynekol; 1991 Nov; 56(5-6):355-60. PubMed ID: 1815843
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.